UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients

Gastroenterology (New York, N.Y. 1943), 2004-11, Vol.127 (5), p.1347-1355

2004

Volltextzugriff (PDF)

Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C

Hepatology (Baltimore, Md.), 2005-04, Vol.41 (4), p.832-835

2005

Volltextzugriff (PDF)

Unwilling or unable? Using three-dimensional tracking to evaluate dogs' reactions to differing human intentions

Proceedings of the Royal Society. B, Biological sciences, 2023-01, Vol.290 (1991), p.20221621-20221621

2023

Volltextzugriff (PDF)

Faldaprevir combined with pegylated interferon alfa‐2a and ribavirin in treatment‐naïve patients with chronic genotype1 HCV: SILEN‐C1 trial

Hepatology (Baltimore, Md.), 2013-06, Vol.57 (6), p.2143-2154

2013

Volltextzugriff (PDF)

A helium mini‐cryostat for the nanoprobe beamline ID16B at ESRF: characteristics and performance

Journal of synchrotron radiation, 2020-07, Vol.27 (4), p.1074-1079

2020

Volltextzugriff (PDF)

Faldaprevir combined with peginterferon alfa‐2a and ribavirin in chronic hepatitis C virus genotype‐1 patients with prior nonresponse: SILEN‐C2 trial

Hepatology (Baltimore, Md.), 2013-06, Vol.57 (6), p.2155-2163

2013

Volltextzugriff (PDF)

Note: Improved wire-wound heater

Review of scientific instruments, 2015-01, Vol.86 (1)

2015

Volltextzugriff (PDF)

Thigh compartment syndrome after intramedullary femoral nailing: Possible femoral nerve block influence on diagnosis timing

Orthopaedics & traumatology, surgery & research, 2009-06, Vol.95 (4), p.309-313

2009

Volltextzugriff (PDF)

Validity of a new disk grading scale for estimating glaucomatous damage: correlation with visual field damage

American journal of ophthalmology, 2002-06, Vol.133 (6), p.758-763

2002

Volltextzugriff (PDF)

1249 BI201335 PHARMACOKINETICS AND EARLY EFFECT ON VIRAL LOAD IN HCV GENOTYPE-1 PATIENTS

Journal of hepatology, 2011-03, Vol.54, p.S493-S493

2011

Volltextzugriff (PDF)

1236 MECHANISMS OF ISOLATED UNCONJUGATED HYPERBILIRUBINEMIA INDUCED BY THE HCV NS3/4A PROTEASE INHIBITOR BI201335

Journal of hepatology, 2011-03, Vol.54, p.S488-S488

2011

Volltextzugriff (PDF)

1185 CHARACTERIZATION OF HCV NS3 VARIANTS THAT EMERGED DURING VIROLOGIC BREAKTHROUGH AND RELAPSE FROM BI 201335 PHASE II SILEN-C2 STUDY IN PEGIFN/RBV TREATMENT-EXPERIENCED PATIENTS

Journal of hepatology, 2012-04, Vol.56, p.S469-S469

2012

Volltextzugriff (PDF)

Mechanisms underlying benign and reversible unconjugated hyperbilirubinemia observed with faldaprevir administration in hepatitis C virus patients

The Journal of pharmacology and experimental therapeutics, 2014-11, Vol.351 (2), p.403-412

2014

Volltextzugriff (PDF)

954 BI 201335, A POTENT HCV NS3 PROTEASE INHIBITOR, IN TREATMENT-NAIVE AND -EXPERIENCED CHRONIC HCV GENOTYPE-1 INFECTION: GENOTYPIC AND PHENOTYPIC ANALYSIS OF THE NS3 PROTEASE DOMAIN

Journal of hepatology, 2009-04, Vol.50, p.S347-S347

2009

Volltextzugriff (PDF)

Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2004-02, Vol.63 (2), p.170-176

2004

Volltextzugriff (PDF)

Su1025 Interferon-Stimulated Gene Expression Is Associated With Treatment Response to Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin in Patients With Chronic HCV Genotype-1 Infection

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-965-S-966

2014

Volltextzugriff (PDF)

60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION

Journal of hepatology, 2011-03, Vol.54, p.S27-S27

2011

Volltextzugriff (PDF)

1231 SVR AND PHARMACOKINETICS OF THE HCV PROTEASE INHIBITOR BI201335 WITH PEGIFN/RBV IN HCV GENOTYPE-1 PATIENTS WITH COMPENSATED LIVER CIRRHOSIS AND NON-RESPONSE TO PREVIOUS PEGIFN/RBV

Journal of hepatology, 2011-03, Vol.54, p.S486-S486

2011

Volltextzugriff (PDF)

Adult presentation of MCAD deficiency revealed by coma and severe arrythmias

Intensive care medicine, 2003-09, Vol.29 (9), p.1594-1597

2003

Volltextzugriff (PDF)

Interferon-gamma in the prevention of severe burn-related infections: A European phase III multicenter trial

Critical care medicine, 1998-03, Vol.26 (3), p.434-439

1998

Volltextzugriff (PDF)

66 SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/R

Journal of hepatology, 2011-03, Vol.54, p.S30-S30

2011

Volltextzugriff (PDF)

Syndrome de loge de la cuisse après enclouage de fémur à propos d’un cas : rôle éventuel du bloc fémoral dans le retard diagnostique

Revue de chirurgie orthopédique et traumatologique, 2009-06, Vol.95 (4), p.374-378

2009

Volltextzugriff (PDF)

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study

Melanoma research, 1999-10, Vol.9 (5), p.491-502

1999

Volltextzugriff (PDF)

1190 SILEN-C2: EARLY ANTIVIRAL ACTIVITY AND SAFETY OF BI 201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (PEGIFN/RBV) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO PEGIFN/RBV

Journal of hepatology, 2010, Vol.52, p.S462-S463

2010

Volltextzugriff (PDF)

1 – 25 von 794

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(654)
Mit Volltextzugriff
(638)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(653)
Deutsch
(131)
Französisch
(12)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients

Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C

Unwilling or unable? Using three-dimensional tracking to evaluate dogs' reactions to differing human intentions

Faldaprevir combined with pegylated interferon alfa‐2a and ribavirin in treatment‐naïve patients with chronic genotype1 HCV: SILEN‐C1 trial

A helium mini‐cryostat for the nanoprobe beamline ID16B at ESRF: characteristics and performance

Faldaprevir combined with peginterferon alfa‐2a and ribavirin in chronic hepatitis C virus genotype‐1 patients with prior nonresponse: SILEN‐C2 trial

Note: Improved wire-wound heater

Thigh compartment syndrome after intramedullary femoral nailing: Possible femoral nerve block influence on diagnosis timing

Validity of a new disk grading scale for estimating glaucomatous damage: correlation with visual field damage

1249 BI201335 PHARMACOKINETICS AND EARLY EFFECT ON VIRAL LOAD IN HCV GENOTYPE-1 PATIENTS

1236 MECHANISMS OF ISOLATED UNCONJUGATED HYPERBILIRUBINEMIA INDUCED BY THE HCV NS3/4A PROTEASE INHIBITOR BI201335

1185 CHARACTERIZATION OF HCV NS3 VARIANTS THAT EMERGED DURING VIROLOGIC BREAKTHROUGH AND RELAPSE FROM BI 201335 PHASE II SILEN-C2 STUDY IN PEGIFN/RBV TREATMENT-EXPERIENCED PATIENTS

Mechanisms underlying benign and reversible unconjugated hyperbilirubinemia observed with faldaprevir administration in hepatitis C virus patients

954 BI 201335, A POTENT HCV NS3 PROTEASE INHIBITOR, IN TREATMENT-NAIVE AND -EXPERIENCED CHRONIC HCV GENOTYPE-1 INFECTION: GENOTYPIC AND PHENOTYPIC ANALYSIS OF THE NS3 PROTEASE DOMAIN

Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis

Su1025 Interferon-Stimulated Gene Expression Is Associated With Treatment Response to Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin in Patients With Chronic HCV Genotype-1 Infection

60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION

1231 SVR AND PHARMACOKINETICS OF THE HCV PROTEASE INHIBITOR BI201335 WITH PEGIFN/RBV IN HCV GENOTYPE-1 PATIENTS WITH COMPENSATED LIVER CIRRHOSIS AND NON-RESPONSE TO PREVIOUS PEGIFN/RBV

Adult presentation of MCAD deficiency revealed by coma and severe arrythmias

Interferon-gamma in the prevention of severe burn-related infections: A European phase III multicenter trial

66 SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/R

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

Syndrome de loge de la cuisse après enclouage de fémur à propos d’un cas : rôle éventuel du bloc fémoral dans le retard diagnostique

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study

1190 SILEN-C2: EARLY ANTIVIRAL ACTIVITY AND SAFETY OF BI 201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (PEGIFN/RBV) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO PEGIFN/RBV

Suchergebnisse filtern